1671-5144
2008 Issue 4
..............page:257
..............page:223
Multimodality Therapy of Hilar Cholangiocarcinoma
guang dong sheng ren min yi yuan zhong liu zhong xin gan dan yi zhong liu wai ke
guang dong sheng ren min yi yuan zhong liu zhong xin gan dan yi zhong liu wai ke
..............page:252-256
..............page:251
ren shi e xing zhong liu cai hui he li zhi liao (1)
wu huai shen
wu huai shen
..............page:251
..............page:249-251
..............page:248-249
..............page:248
2006 Consensus Guidelines for the Management of Women with Abnormal Cervical Cancer Screening Tests
Thomas C.Wrisht Jr;L.Stewart Massad;Charles J. Dunton;Mark Spitzer;Edward J. Wilkinson;Diane Solomon;LI Zhi-gang
Thomas C.Wrisht Jr;L.Stewart Massad;Charles J. Dunton;Mark Spitzer;Edward J. Wilkinson;Diane Solomon;LI Zhi-gang
..............page:239-247
How to Appraise and Implement Clinical Practice Guideline for Clinicians
YANG Ming;DONG Bi-rong
YANG Ming;DONG Bi-rong
..............page:235-238
Stata in Assessing Heterogeneity in Meta-Analysis
ZHANG Tian-song;ZHONG Wen-zhao;ZHANG Su;LI Xiu-juan
ZHANG Tian-song;ZHONG Wen-zhao;ZHANG Su;LI Xiu-juan
..............page:231-234
Correct Statistical Test to Find the Equivalence between Two Clinical Treatment Effects
ZHANG Hai-ning;ZHANG Jin-xin;XUE Yun-lian;ZHANG Xi;WANG Xiao
ZHANG Hai-ning;ZHANG Jin-xin;XUE Yun-lian;ZHANG Xi;WANG Xiao
..............page:228-230
Meta-Analysis of Difference between Quetiapine Combining Antidepressant and Single Antidepressant in Treatment of Depression
LIU Lan-ying;MA Yong-chun;JIN Wei-dong;WANG He-qiu
LIU Lan-ying;MA Yong-chun;JIN Wei-dong;WANG He-qiu
..............page:224-227
The Meta-Analysis for the Effects of Letrozole and Clomiphene Citrate for Ovulation Induction in Women with Polycystic Ovarian Syndrome
LIU Ying;WEN An-min;Mosammat Rashida Begum
LIU Ying;WEN An-min;Mosammat Rashida Begum
..............page:219-223
KRAS Mutations and Primary Resistance of Lung Adenocarcinomas to Gefitinib or Erlotinib
QIAO Gui-bin;CHENG Hua
QIAO Gui-bin;CHENG Hua
..............page:216-218
c-Met Amplification in Non-Small Cell Lung Cancer with Acquired Resistance to Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitors
HAN Bao-hui;CHEN Hua-jun
HAN Bao-hui;CHEN Hua-jun
..............page:213-215
HKI-272 and Rapamycin Combination Therapy Overcome the Acquired Resistance of EGFR-TKI in Non-Small Cell Lung Cancer
GUO Ai-lin;ZONG Sa
GUO Ai-lin;ZONG Sa
..............page:210-212,215
The Origin, Inherited Susceptibility and Nature Selection in Vivo of T790M
YU Xi-yong;CHEN Si-yuan
YU Xi-yong;CHEN Si-yuan
..............page:205-209
Acquired Resistance of Lung Adenocarcinomas to Tyrosine Kinase Inhibitors Is Associated with T790M Mutation in the EGFR Kinase Domain
WANG Jie;BAI Xiao-yan
WANG Jie;BAI Xiao-yan
..............page:201-204
Mutant-Enrich PCR Assay in T790M and the Theory of Clone Evolution
FU Li-wu;JIANG Ben-yuan
FU Li-wu;JIANG Ben-yuan
..............page:198-200
The Bottleneck of EGFR-TKI Application in Non-Small Cell Lung Cancer——Acquired Resistance
ZHONG Wen-zhao;WU Yi-long
ZHONG Wen-zhao;WU Yi-long
..............page:193-197